Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial

Introduction and Aims: There has been a rapid increase in smoking crystalline methamphetamine in Australia. We compare the clinical and demographic characteristics of those who smoke versus inject the drug in a cohort of people who use methamphetamine. Design and Methods: Participants (N = 151) were...

Full description

Bibliographic Details
Main Authors: McKetin, Rebecca, Quinn, B., Higgs, Peter, Berk, M., Dean, O.M., Turner, A., Kelly, P.J., Lubman, D.I., Carter, G., Baker, A.L., Manning, V., Thomas, T., Bathish, R., Raftery, D., Saunders, L., Wrobel, A., Meehan, A., Sinclair, B., Reid, D., Arunogiri, S., Hill, H., Cordaro, F., Dietze, Paul
Format: Journal Article
Language:English
Published: WILEY 2021
Subjects:
Online Access:http://purl.org/au-research/grants/nhmrc/1128147
http://hdl.handle.net/20.500.11937/91412
_version_ 1848765514637115392
author McKetin, Rebecca
Quinn, B.
Higgs, Peter
Berk, M.
Dean, O.M.
Turner, A.
Kelly, P.J.
Lubman, D.I.
Carter, G.
Baker, A.L.
Manning, V.
Thomas, T.
Bathish, R.
Raftery, D.
Saunders, L.
Wrobel, A.
Meehan, A.
Sinclair, B.
Reid, D.
Arunogiri, S.
Hill, H.
Cordaro, F.
Dietze, Paul
author_facet McKetin, Rebecca
Quinn, B.
Higgs, Peter
Berk, M.
Dean, O.M.
Turner, A.
Kelly, P.J.
Lubman, D.I.
Carter, G.
Baker, A.L.
Manning, V.
Thomas, T.
Bathish, R.
Raftery, D.
Saunders, L.
Wrobel, A.
Meehan, A.
Sinclair, B.
Reid, D.
Arunogiri, S.
Hill, H.
Cordaro, F.
Dietze, Paul
author_sort McKetin, Rebecca
building Curtin Institutional Repository
collection Online Access
description Introduction and Aims: There has been a rapid increase in smoking crystalline methamphetamine in Australia. We compare the clinical and demographic characteristics of those who smoke versus inject the drug in a cohort of people who use methamphetamine. Design and Methods: Participants (N = 151) were dependent on methamphetamine, aged 18–60 years, enrolled in a pharmacotherapy trial for methamphetamine dependence, and reported either injecting (n = 54) or smoking (n = 97) methamphetamine. Measures included the Timeline Followback, Severity of Dependence Scale, Amphetamine Withdrawal Questionnaire, Craving Experience Questionnaire and the Brief Psychiatric Rating Scale (symptoms of depression, hostility, psychosis and suicidality). Simultaneous regression was used to identify independent demographic correlates of smoking methamphetamine and to compare the clinical characteristics of participants who smoked versus injected. Results: Compared to participants who injected methamphetamine, those who smoked methamphetamine were younger and less likely to be unemployed, have a prison history or live alone. Participants who smoked methamphetamine used methamphetamine on more days in the past 4 weeks than participants who injected methamphetamine (26 vs. 19 days, P = 0.001); they did not differ significantly in their severity of methamphetamine dependence, withdrawal, craving or psychiatric symptoms (P > 0.05). After adjustment for demographic differences, participants who smoked had lower craving [b (SE) = −1.1 (0.5), P = 0.021] and were less likely to report psychotic symptoms [b (SE) = −1.8 (0.7), P = 0.013] or antidepressant use [b (SE) = −1.1 (0.5), P = 0.022]. Discussion and Conclusions: Smoking crystalline methamphetamine is associated with a younger less marginalised demographic profile than injecting methamphetamine, but a similarly severe clinical profile.
first_indexed 2025-11-14T11:36:28Z
format Journal Article
id curtin-20.500.11937-91412
institution Curtin University Malaysia
institution_category Local University
language English
last_indexed 2025-11-14T11:36:28Z
publishDate 2021
publisher WILEY
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-914122023-04-19T03:54:32Z Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial McKetin, Rebecca Quinn, B. Higgs, Peter Berk, M. Dean, O.M. Turner, A. Kelly, P.J. Lubman, D.I. Carter, G. Baker, A.L. Manning, V. Thomas, T. Bathish, R. Raftery, D. Saunders, L. Wrobel, A. Meehan, A. Sinclair, B. Reid, D. Arunogiri, S. Hill, H. Cordaro, F. Dietze, Paul Science & Technology Life Sciences & Biomedicine Substance Abuse methamphetamine pharmacotherapy characteristics inject smoke PSYCHOMETRIC PROPERTIES DRUG-USE HARMS USERS DEPENDENCE SEVERITY COCAINE HEROIN characteristics inject methamphetamine pharmacotherapy smoke Adolescent Adult Amphetamine-Related Disorders Australia Central Nervous System Stimulants Demography Humans Methamphetamine Middle Aged Smoking Young Adult Humans Amphetamine-Related Disorders Methamphetamine Central Nervous System Stimulants Smoking Demography Adolescent Adult Middle Aged Australia Young Adult Introduction and Aims: There has been a rapid increase in smoking crystalline methamphetamine in Australia. We compare the clinical and demographic characteristics of those who smoke versus inject the drug in a cohort of people who use methamphetamine. Design and Methods: Participants (N = 151) were dependent on methamphetamine, aged 18–60 years, enrolled in a pharmacotherapy trial for methamphetamine dependence, and reported either injecting (n = 54) or smoking (n = 97) methamphetamine. Measures included the Timeline Followback, Severity of Dependence Scale, Amphetamine Withdrawal Questionnaire, Craving Experience Questionnaire and the Brief Psychiatric Rating Scale (symptoms of depression, hostility, psychosis and suicidality). Simultaneous regression was used to identify independent demographic correlates of smoking methamphetamine and to compare the clinical characteristics of participants who smoked versus injected. Results: Compared to participants who injected methamphetamine, those who smoked methamphetamine were younger and less likely to be unemployed, have a prison history or live alone. Participants who smoked methamphetamine used methamphetamine on more days in the past 4 weeks than participants who injected methamphetamine (26 vs. 19 days, P = 0.001); they did not differ significantly in their severity of methamphetamine dependence, withdrawal, craving or psychiatric symptoms (P > 0.05). After adjustment for demographic differences, participants who smoked had lower craving [b (SE) = −1.1 (0.5), P = 0.021] and were less likely to report psychotic symptoms [b (SE) = −1.8 (0.7), P = 0.013] or antidepressant use [b (SE) = −1.1 (0.5), P = 0.022]. Discussion and Conclusions: Smoking crystalline methamphetamine is associated with a younger less marginalised demographic profile than injecting methamphetamine, but a similarly severe clinical profile. 2021 Journal Article http://hdl.handle.net/20.500.11937/91412 10.1111/dar.13183 English http://purl.org/au-research/grants/nhmrc/1128147 http://purl.org/au-research/grants/nhmrc/1135901 http://purl.org/au-research/grants/nhmrc/1136908 http://purl.org/au-research/grants/nhmrc/1156072 http://purl.org/au-research/grants/nhmrc/1145634 http://purl.org/au-research/grants/nhmrc/1059660 WILEY fulltext
spellingShingle Science & Technology
Life Sciences & Biomedicine
Substance Abuse
methamphetamine
pharmacotherapy
characteristics
inject
smoke
PSYCHOMETRIC PROPERTIES
DRUG-USE
HARMS
USERS
DEPENDENCE
SEVERITY
COCAINE
HEROIN
characteristics
inject
methamphetamine
pharmacotherapy
smoke
Adolescent
Adult
Amphetamine-Related Disorders
Australia
Central Nervous System Stimulants
Demography
Humans
Methamphetamine
Middle Aged
Smoking
Young Adult
Humans
Amphetamine-Related Disorders
Methamphetamine
Central Nervous System Stimulants
Smoking
Demography
Adolescent
Adult
Middle Aged
Australia
Young Adult
McKetin, Rebecca
Quinn, B.
Higgs, Peter
Berk, M.
Dean, O.M.
Turner, A.
Kelly, P.J.
Lubman, D.I.
Carter, G.
Baker, A.L.
Manning, V.
Thomas, T.
Bathish, R.
Raftery, D.
Saunders, L.
Wrobel, A.
Meehan, A.
Sinclair, B.
Reid, D.
Arunogiri, S.
Hill, H.
Cordaro, F.
Dietze, Paul
Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial
title Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial
title_full Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial
title_fullStr Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial
title_full_unstemmed Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial
title_short Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial
title_sort clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in australia: findings from a pharmacotherapy trial
topic Science & Technology
Life Sciences & Biomedicine
Substance Abuse
methamphetamine
pharmacotherapy
characteristics
inject
smoke
PSYCHOMETRIC PROPERTIES
DRUG-USE
HARMS
USERS
DEPENDENCE
SEVERITY
COCAINE
HEROIN
characteristics
inject
methamphetamine
pharmacotherapy
smoke
Adolescent
Adult
Amphetamine-Related Disorders
Australia
Central Nervous System Stimulants
Demography
Humans
Methamphetamine
Middle Aged
Smoking
Young Adult
Humans
Amphetamine-Related Disorders
Methamphetamine
Central Nervous System Stimulants
Smoking
Demography
Adolescent
Adult
Middle Aged
Australia
Young Adult
url http://purl.org/au-research/grants/nhmrc/1128147
http://purl.org/au-research/grants/nhmrc/1128147
http://purl.org/au-research/grants/nhmrc/1128147
http://purl.org/au-research/grants/nhmrc/1128147
http://purl.org/au-research/grants/nhmrc/1128147
http://purl.org/au-research/grants/nhmrc/1128147
http://hdl.handle.net/20.500.11937/91412